Dr. Matthew D. Bauer, DO
Infectious Disease (Infectious Disease Physician)
- Medicare participating
At a glance
- Medical school
- University of Pikeville, Kentucky College of Osteopathic Med (2012)
- Years since graduation
- 14
- In the NPI registry since
- 2012
- Medicare patients seen, 2024
- 40
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Medical school: University of Pikeville, Kentucky College of Osteopathic Med
- 2012Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Infectious Disease Physician primary
OH license 34.011699 -
Internal Medicine Physician
OH license 34.011699
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare patients and services
- Medicare patients, 2024
- 40
- Services billed
- 43
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 12 | 12 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 12 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Biktarvy (bictegrav/emtricit/tenofov ala) | 24 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 9 payments worth $357 in total to this clinician.
| Gilead Sciences, Inc. | $167 |
|---|---|
| Viiv Healthcare Company | $122 |
| Merck Sharp & Dohme LLC | $19.10 |
| GlaxoSmithKline, LLC. | $17.10 |
| AstraZeneca Pharmaceuticals LP | $16.21 |
| Pfizer Inc. | $16.07 |
| Food and Beverage | $357 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.